Sofwave Medical

Sofwave Medical Equity

The The Equity of Sofwave Medical (SOFW.TA) as of Oct 26, 2026 is 24.53 M USD. In the previous year, The Equity was 26.34 M USD — a change of -6.90% (lower).

Equity

24.53 MUSD

YoY

-6.90%

Last updated:

In 2024, Sofwave Medical's equity was 24.53 M USD, a -6.90% increase from the 26.34 M USD equity in the previous year.

The Sofwave Medical Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
1.53 M USD
Jan 1, 2021
46.70 M USD
Jan 1, 2022
32.34 M USD
Jan 1, 2023
26.34 M USD
Jan 1, 2024
24.53 M USD
The Sofwave Medical Equity history
YEAREquityYoY
24.53 MUSD-6.90%
26.34 MUSD-18.54%
32.34 MUSD-30.75%
46.70 MUSD+2,952.29%
1.53 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sofwave Medical Stock analysis

What does Sofwave Medical do? Sofwave Medical Ltd, based in Yokneam, Israel, develops, produces, and markets medical devices for skin rejuvenation and firming using non-invasive Synchronous Ultrasound Parallel Beam (SUPERB) technology. The company operates globally, with a subsidiary in the United States, offering solutions for facial and neck treatments that provide safe, clinically effective skin tightening without surgery. Its products are distributed through its own channels and subsidiaries. Sofwave Medical is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sofwave Medical's Equity

Sofwave Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sofwave Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sofwave Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sofwave Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sofwave Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sofwave Medical stock

The Equity of Sofwave Medical is 24.53 M USD in 2024.

The Equity of Sofwave Medical changed from 26.34 M USD to 24.53 M USD, representing a -6.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sofwave Medical since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sofwave Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Sofwave Medical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Sofwave Medical